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Abstract: Purpose Anastomotic leakages or staple line defects after Roux-en-Y gastric bypass (RYGB)
and primary laparoscopic sleeve gastrectomy (LSG), respectively, with consecutive bariatric revisional
surgery are associated with relevant morbidity and mortality rates. Endoscopic vacuum therapy (EVT)
with or without stent-over-sponge (SOS) has been shown to be a promising therapy in foregut wall defects
of various etiologies and may therefore be applied in the treatment of postbariatric leaks. Methods We
report the results of six consecutive patients treated with EVT (83% in combination with SOS) for
early postoperative leakages in close proximity to the esophagogastric junction (EGJ) after LSG (n = 2)
and RYGB (n = 4) from May 2016 to May2018. Results All patients (2/6 male, median age 51 years,
median BMI 44.2 kg/m2) were treated successfully without further signs of persisting leakage at the last
gastroscopy. The lesions’ size ranged from 0.5 cm2 to 9 cm2, and the leaks were connected to large (max.
225 cm2) abscess cavities in 80% of the cases. Median duration of treatment (= EVT in situ) was 23.5
days (range, 7–89). The number of endoscopic interventions ranged from 1 to 24 (median, n = 7), with
a median duration between vacuum sponge replacements of 4 days. Conclusion EVT is an effective and
safe treatment for staple line defects or anastomotic leakage after bariatric surgeries and can therefore
be adopted for the treatment of midgut wall defects. Further studies with a greater number of patients
comparing surgical drainage alone or in combination with EVT versus EVT alone are needed.
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Abstract: Purpose:
Anastomotic leakages or staple line defects after Roux-en-Y gastric bypass (RYGB)
and primary laparoscopic sleeve gastrectomy (LSG), respectively, with consecutive
bariatric revisional surgery are associated with relevant morbidity and mortality rates.
Endoscopic vacuum therapy (EVT) with or without stent-over-sponge (SOS) has been
shown to be a promising therapy in foregut wall defects of various etiologies and may
therefore be applied in the treatment of postbariatric leaks.
Methods:
We report the results of 6 consecutive patients treated with EVT (83% in combination
with SOS) for early postoperative leakages in close proximity to the esophagogastric
junction (EGJ) after LSG (n=2) and RYGB (n=4) from 05/2016 to 05/2018.
Results:
All patients (2/6 male, median age 51 years, median BMI 44.2 kg/m2) were treated
successfully without further signs of persisting leakage at the last gastroscopy. The
lesions’ size ranged from 0,5 cm2 to 9 cm2 and the leaks were connected to large
(max. 225 cm2) abscess cavities in 80% of the cases. Median duration of treatment
(=EVT in situ) was 23.5 days (range, 7-89). The number of endoscopic interventions
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ranged from 1 to 24 (median, n=7), with a median duration between vacuum sponge
replacements of 4 days.
Conclusion:
EVT is an effective and safe treatment for staple line defects or anastomotic leakage
after bariatric surgeries and can therefore be adopted for the treatment of midgut wall
defects. Further studies with a greater a number of patients comparing surgical
drainage alone or in combination with EVT versus EVT alone are needed.
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using both at the same time would most likely be prohibitive in most health care systems of the world.  
 
Thank you for this important comment. We do agree that expenditures caused by repeated 
endoscopies are a major concern. We therefore added a section in the discussion of the manuscript, 
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treatment modalities appears to be justified in this vulnerable patient cohort, since treatment failure 
may result in prolonged hospital stays, which generate additional costs, or worse, in death of the 
patient. However further studies are definitely needed. 
 
2: I would like that the authors discuss the benefits of the additional EndoVac on top of the stent 
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patients requiring aggressive treatment, e.g. in critically ill patients with large defects resulting in a high 
risk of sponge displacements. 
 
3: The discussion about prophylactic EndoVac therapy is in my opinion out of place. The authors 
provide no data whatsoever on the prophylactic use. Just because they started doing that in 
esophagectomy does not warrant this statement in this manuscript, especially since the available data 
on prophylactic EndoVac is not that convincing.  
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2: Furthermore SEMS is an expensive therapy and the authors report on one patient having 16 times 
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against cost and risks.  
 
Thank you for this comment. Please see our response to comments 1 and 2 of reviewer #2. 
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stripping occured during extraction of the SEMS, which is a well known complication of partially 
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Thank you for this important comment. The rationale to use partially covered SEMS was the smaller 
risk of stent migrations. Nonetheless, SEMS migration occurred in one patient. This information was 
added to the manuscript. 
 
4: The authors state, that the median number of days between diagnosis of anastomotic leakage and 
beginning of EVT was 2.5 days. Why did the therapy not start immediately? 
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Anastomotic leakages or staple line defects after Roux-en-Y gastric bypass (RYGB) and primary 
laparoscopic sleeve gastrectomy (LSG), respectively, with consecutive bariatric revisional surgery are 
associated with relevant morbidity and mortality rates. Endoscopic vacuum therapy (EVT) with or 
without stent-over-sponge (SOS) has been shown to be a promising therapy in foregut wall defects of 
various etiologies and may therefore be applied in the treatment of postbariatric leaks. 
 
Methods: 
We report the results of 6 consecutive patients treated with EVT (83% in combination with SOS) for 
early postoperative leakages in close proximity to the esophagogastric junction (EGJ) after LSG (n=2) 
and RYGB (n=4) from 05/2016 to 05/2018.  
 
Results: 
All patients (2/6 male, median age 51 years, median BMI 44.2 kg/m2) were treated successfully 
without further signs of persisting leakage at the last gastroscopy. The lesions’ size ranged from 0,5 
cm2 to 9 cm2 and the leaks were connected to large (max. 225 cm2) abscess cavities in 80% of the 
cases. Median duration of treatment (=EVT in situ) was 23.5 days (range, 7-89). The number of 
endoscopic interventions ranged from 1 to 24 (median, n=7), with a median duration between vacuum 
sponge replacements of 4 days. 
 
Conclusion: 
EVT is an effective and safe treatment for staple line defects or anastomotic leakage after bariatric 
surgeries and can therefore be adopted for the treatment of midgut wall defects. Further studies with a 
greater a number of patients comparing surgical drainage alone or in combination with EVT versus 
EVT alone are needed.  
Keywords: Endoscopic vacuum therapy, stent-over-sponge, laparoscopic sleeve gastrectomy, Roux-






Study concept and design: Bernhard Morell, Fritz Murray, Christoph Gubler 
Acquisition of data: Bernhard Morell, Fritz Murray, Marco Bueter 
Analysis and interpretation of data: Bernhard Morell, Fritz Murray, Christoph Gubler 
Drafting of manuscript: Bernhard Morell, Fritz Murray 




Since 1975, the worldwide prevalence of obesity has nearly tripled [1] and is associated with 
substantial comorbidities and a noteworthy economic burden. Currently, laparoscopic sleeve 
gastrectomy (LSG) and Roux-en-Y gastric bypass (RYGB) comprise the most efficient therapies in 
treating morbid obesity.  
Despite the relatively low incidence of post-bariatric surgery leaks ranging between 1.5 %-4.9 % [2-5], 
the growing number of bariatric surgeries leads to a significant increase of complications. It is 
commonly recognized that revisional bariatric operations are (i) technically demanding and (ii) 
associated with intra- and postoperative complications thereby carrying a severalfold increased risk of 
mortality [6, 7].  
During the last decade, interventional endoscopy has become an invaluable alternative or addition to 
revisional surgery. Hitherto, the endoscopic placement of self-expandable metal stents (SEMS) has 
been regarded as the mainstay of the endoscopic management with post bariatric leak closure of up to 
88% [8]. However, stent related complications such as stent migration, local pressure necrosis, 
bleeding, mucosal ulcers and strictures are frequently encountered adverse events. In the 
management of post bariatric complications, SEMS treatment is further hampered by the frequent 
requirement for supplementary abscess drainage to prevent or treat sepsis. Due to the mentioned 
limitations, SEMS has been challenged by endoscopic vacuum therapy (EVT) that was first introduced 
for the treatment of anastomotic leakage complicating rectal resection [9, 10]. Vacuum therapy using a 
polyurethane foam has the ability to seal the leak, thereby decreasing bacterial contamination, 
promoting vascularity, and propagating the formation of granulation tissue [11, 12]. In fact, 
retrospective studies suggest that EVT may by superior to other treatment modalities [13-15]. In 2013 
our group introduced the stent-over-sponge (SOS) treatment which combines EVT with SEMS 
placement [16]. In selected cases, this technique optimizes vacuum therapy by directing the vacuum 
force towards the defect which in our experience results in faster ingrowth of granulation tissue, thus 
promoting more rapid closure of the defect. Only scant literature, however, exists on EVT in bariatric 





MATERIAL AND METHODS 
Patient selection 
We herein describe the endoscopic treatment of six consecutive patients (2/6 male, median age 51.5 
years, median BMI 44.3 kg/m2, median preoperative weight 133.5 kg; for detailed patient 
characteristics see table 1) that were treated with EVT for early postoperative anastomotic leakages 
after primary LSG (n=2) and RYGB (n=4) at our institution between May 2016 to May 2018. Four 
patients (# 1, 2, 5 and 6) were referred from other hospitals after the initial treatment of the 
postoperative leak had failed. 
Endoscopic interventions 
All endoscopies were conducted with Olympus single-channel gastroscopes (Olympus Medical 
Systems, Tokyo, Japan). The technical aspects of the endoscopic procedures (EVT and SOS) have 
been previously described [16, 19]. Briefly, the initial endoscopic assessment included an 
approximative assessment of the dehiscence dimensions in reference to standard biopsy forceps. The 
placement of the Eso-SPONGE® (B. Braun Melsungen AG, Melsungen, Germany) consisting of an 
open-pored polyurethane sponge fitted to a gastric tube was aided by a previous endoscopic 
placement of an overtube provided by the manufacturer. Using the Eso-SPONGE® pusher, the foam 
was directly placed into the wall defect, or in case of large perforations into abscess cavities (fig. 1). In 
two patients the sponge placement was complicated due to angulation of the opening towards the 
wound cavity. Hence, the insertion had to be performed applying the “backpack-method”, i.e. the 
sponge was pulled in to cavity using a forceps after a suture loop was attached to the tip to the loop. 
After optimal placement, continuous negative pressure of 75 mmHg was applied over the sponge 
suction tube which was connected to a vacuum device (VAC Medela, Baar, Switzerland). In 83% of 
the presented cases the stent-over-sponge (SOS) technique was applied at least once as described 
previously by our group [16]. In brief, after insertion of the foam into the wound cavity, a partially 
covered SEMS (Ultraflex Esophageal NG, Boston Scientific, Marlborough, Massachusetts, USA; or 
Hanaro Esophagus, M.I. Tech, Pyeongtaek, South Korea) was placed over the foam in order to avoid 
dislodging from the correct position. The SOS technique was applied if the wall defect was considered 
too large to be sealed by the sponge in order to prevent muddy reflux into the cavity or in case of 
smaller defects, the luminal placement appeared to be ineffective. A scheme of the described 
endoscopic interventions is shown in figure 2. The sponge was replaced every 3-5 days in order to 
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prevent ingrowth of granulation tissue. Vacuum therapy was considered successful if no macroscopic 
evidence for a persisting dehiscence was visible after final sponge removal without subsequent need 
for any surgical intervention. All treatments were performed in accordance to previous institutional 
experiences aiming for a prospective analysis. All patients signed the written informed consent for the 





We retrospectively analyzed 6 consecutive patients who were treated endoscopically at our institution 
for leakage in the upper gastrointestinal tract after bariatric surgery between 2016 and 2018. All 
treated complications were considered early occurring within a median of 3.5 postoperative days 
(range 3-9). In five of the six cases, diagnosis was made by computed tomography (CT). In the 
remaining case (1/6), a dehiscence was solely seen during diagnostic gastroscopy. In the patients 
undergoing LSG, as underlying defect staple line rupture was found (2/6). In case of the leaks post 
RYGB (4/6), anastomotic leakage was detected. The median number of days between diagnosis of 
the anastomotic leakage and the beginning of EVT was 2.5 days (range 1-7), resulting in a median of 
7.5 days (range 4-11) after the initial bariatric surgery. All leakages or defects were located distally to 
the diaphragm in close proximity to the gastroesophageal junction (EGJ) with an endoscopically 
measured distance to the teeth ranging from 39 to 50cm. In 5/6 of the patients (83%) the leakages or 
staple line defects, respectively, were connected to considerably large (up to 15x15cm) 
infradiaphragmatic abscess cavities. Prior to EVT, a total of three patients (#3, 4 and 6) underwent 
surgical repair which was combined with the placement of a self-expandable metal stent (SEMS) in 
one case (patient #4). Another patient (#5) underwent SEMS placement along with laparoscopic 
lavage prior to EVT. 
Clinical course and procedure related complications 
No therapy related severe adverse events were observed. Of note, none of the patients operated at 
our institution developed sepsis nor needed to be referred to the intensive care unit. In one patient 
(patient # 1) esophageal wall stripping occurred when the SEMS was extracted and an enlarging 
intraperitoneal abscess cavity with extension to the spleen had to be laparoscopically drained. In the 
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same patient, great care was taken that the foam was not in contact with the spleen to prevent 
potential splenic hemorrhage. Over the course of the prolonged hospital stay with a total of 9 sponge 
replacements, the patient was diagnosed with adjustment disorder, requiring psychiatric counseling. 
Two of the four patients that were referred to our hospital presented with secondary acute respiratory 
distress syndrome which required initiation of extracorporal membrane oxygenation before referral to 
our institution. In one of these patients (#5), the application of Padlock Clip™ to close a fistula was 
ineffective after 16 sponge treatments had been performed. Subsequently, this patient underwent 
another 8 EVTs which finally resulted in sustained closure of the defect. The other three patients did 
not receive any additional interventional therapy during the course of EVT. The decision to terminate 
EVT was based on visual conformation of a small contained wound cavity, lined by granulation tissue 
(fig. 3). The median duration of EVT was 23.5 days (range 7-89) with a median number of 7 
endoscopic interventions (range 1-24) conducted in a median of four days (range 3-4) in between 
sponge replacements. In 83.3% (5/6 patients) of the cases EVT was combined with SOS. In these five 
patients a median of 5.5 (3-16) SOS-replacements were performed. Representative images of the 
endoscopic procedures are shown in figures 1 and 2. During the course of EVT all patients received 
broad spectrum antibiotics. 
 
DISCUSSION 
A leak complicating bariatric surgery represents still a life threatening situation and its management 
remains a major clinical challenge. The evidence published on EVT in bariatric patients, however, is 
extremely limited and no guidelines embrace its implementation. To the best of our knowledge, this is 
the largest case series evaluating the clinical course of bariatric patients undergoing EVT due to 
anastomotic or staple line leakage. The rationale to apply EVT in bariatric patients is mainly derived by 
the favorable outcomes observed in the treatment of leakages of various other etiologies, such as 
anastomotic insufficiency secondary to esophagectomy, Boerhaave’s syndrome, or iatrogenic 
perforations [13-15]. Considering the serious instability of two of our patients (# 5 and 6), the clinical 
outcome of our series with no mortality, low EVT-associated morbidity and complete recovery is 
excellent. According to our experience, EVT may reduce the need for percutaneous drainage and 
serves as another argument to forgo routine use of an abdominal drain following bariatric surgery [21]. 
It needs to be emphasized, however, that significant EVT related complications, such as severe 
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hemorrhage due to eroded blood vessel [13] or dislodgement of the foam into the pharynx 
compromising respiration (personal observation beyond this study) occur. In addition to that, 
physicians need to be aware that repeat sponge replacements can lead to considerable psychological 
distress in affected patients. As a result, one patient undergoing 16 sponge placements over a period 
of 89 days developed adjustment disorder that made psychiatric counseling necessary. Whereas most 
publications on EVT in the upper GI tract focus on the treatment of supradiaphragmatic perforations, 
we herein demonstrate the feasibility of EVT distally to the diaphragm in patients with extensive 
defects. By using the “backpack method”, overtube length did not preclude treatment of wall defects in 
the midgut, as they occur in anastomotic leakage of the gastrojejunostomy after RYGB.  
As described above, partially covered SEMS were used instead of fully covered stents based on the 
rationale that the uncovered meshes of the stents may prevent migration [20]. Nonetheless, SEMS 
migration occurred in one patient. 
Since timely treatment of postbariatric leaks is crucial, any treatment delay should be avoided. The lag 
between the diagnosis of the leakage and the initiation of EVT is mainly attributed to the fact that four 
patients (# 1, 2, 5 and 6) were referred from other hospitals. In patient #4, EVT was applied after a 
previous SEMS treatment over a period of 7 days did not result in clinical improvement. 
Undeniably, our study has some limitations. The successful treatment of a limited number of cases 
does not rule out potential treatment failures. Additionally, the question of how to combine the various 
treatment modalities in the management of postbariatric leaks remains unsolved. Since repeat 
inpatient endoscopies are required during EVT, expenditures are of major concern, especially when 
combined with the SOS-principle. As mentioned above, SEMS placement represents another effective 
treatment option [20, 22, 23] with the potential advantage of i) fewer endoscopies and ii) outpatient 
treatment. Relating to the data published by Murino et al. [20] reporting on the outcome for 91 
postbariatric patients, 74 patients could be successfully treated by SEMS application, thereof 36 were 
treated by a single SEMS placement. However, it needs to be emphasized that clinical success rate in 
the cited studies is less than 90% and treatment failure likely results in prolonged hospital stay 
generating additional costs. Therefore, the evaluation of other treatment modalities such as EVT 
appears to be justified. The significant costs generated by the application of the SOS-principle, 
however, should be carefully balanced against their potential benefits. To make an example, in patient 
# 5 requiring 16 SEMS-placements additional costs of approximately 40’000 Swiss francs were 
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generated. It needs to be mentioned, however, that same patient was critically ill needing treatment on 
ICU for 40 days. 
We applied therefore the SOS-principle only when the clinical condition of the patient required 
aggressive treatment and either a mismatch between the size of the leak, the luminal diameter and the 
size of the sponge was postulated or the defect was too large to be sealed by the sponge. By using 
the SOS-method in turn, ineffective application of EVT could be reliably prevented. 
Taking the various arguments together, EVT may be regarded as an effective alternative to SEMS 
placement in patients with large wound cavities that are amenable to sponge placement whereas the 
SOS principle should be reserved for severely ill patients in whom sponge dislodgement is a major 
concern. Prospective studies are paramount to further elucidate the issue of cost-effectiveness, since 
growing number of post-bariatric patients call for resource-sparing treatment algorithms that offer 
guidance in the choice of the optimal treatment strategy in relation to specific patient characteristics. 
Of note, pathophysiology and course of illness in patients with postbariatric leakage depend to some 
extent on the type of bariatric surgery. Leaks in patients undergoing LSG are usually located at the 
angle of His and their treatment may be more time consuming [20, 24] because the sleeved stomach 
represents a high pressure system due to sphincters at both ends. Whereas the limited number of 
patients in our case series does not allow any conclusions to be drawn concerning this matter, trials 
evaluating EVT compared to transpyloric SEMS-treatment in patients with leaks at the angle of His 
would be of great interest. 
Finally, the role of endoscopic internal drainage (EID) by inserting pigtails into collections compared to 
EVT or SEMS treatment has not yet been defined. With respect to EVT, EID may be better tolerated 
and offers the advantage of outpatient treatment. 
 
CONCLUSION 
In summary, EVT is an effective and safe treatment for staple line or anastomotic leakage after 
bariatric surgeries and can be adopted for the treatment of midgut defects. Further studies with a 
greater a number of patients comparing surgical drainage alone or in combination with EVT versus 
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laparoscopic 
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multiple organ failure; 
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secondary ARDS  
22 (7/10)  yes 
 Abbreviations: LSG = laparoscopic sleeve gastrectomy; RYGB = Roux-en-Y gastric bypass; EVT = endoscopic vacuum thearpy; SEMS = self-expandable metal stent; IMC = intermediate care unit; ICU = intensive care unit; ECMO = 








Fig 1 Initial situation patient #1. a initial dehiscence (gastroscopy #1). b enlarged dehiscence with 
visualization of spleen (gastroscopy #4, 11 days after initial EVT). c exemplary CT image showing large 
fluid collection with entrapped air. d esosponge in defect (gastroscopy #6, 18 days after initial EVT) 
 
Figure 2: 
Fig 2 Endoscopic vacuum therapy (EVT) as performed in patient # 1. a EVT was initially applied 
intracavitary. b Care was taken to avoid any contact with the spleen (exemplified by the red line). As the 
cavity diminished in size, the stent-over- sponge (SOS) method was used. 
 
Figure 3: 
Fig 3 Course of treatment patient #1. a Formation of granulation tissue with esosponge in situ 
(gastroscopy #7 24 days after initial EVT). b stent-over-sponge (gastroscopy #7, 24 days after initial 
EVT). c Granulation tissue in former cavity (gastroscopy #9, 31 days after initial EVT). d Final 
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 Abbreviations: LSG = laparoscopic sleeve gastrectomy; RYGB = Roux-en-Y gastric bypass; EVT = endoscopic vacuum thearpy; SEMS = self-expandable metal stent; IMC = intermediate care unit; ICU = intensive care unit; ECMO = 
extracorporeal membrane oxygenation; ARDS = acute respiratory distress syndrom 
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